IL17A and COVID-19: Taking these data together, we can hypothesize that the concomitant increase of IL-12p70 with IL-17A observed in the COVID-19 group with SIgA could be an important feature in order to promote an efficient stimulation of the immune response in the airway’s mucosa, leading to SIgA production.